Regeneration or Risk? A Narrative Review of BPC 157 for Musculoskeletal Healing Current Reviews in Musculoskeletal Medicine Springer Nature Link The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA to weigh easing limits on unproven peptides promoted by RFK Jr.